Only one-third of applications were qualified for the next stage of the Polish Agency for Enterprise Development (PARP) competition. NanoGroup S.A. primarily funds all its innovative research and development projects in the fields of biotechnology and medicine from the company’s own resources. At the same time, the group consistently seeks additional funding sources by applying for grants within programs aligned with NanoGroup’s profile and development mission.
In December 2024, NanoGroup S.A. advanced to the substantive evaluation stage in the Medical Research Agency competition. Now, the company has qualified for the next stage of the PARP competition.
The funds obtained are intended to support the development of a key project— the construction and advancement of the NanOX system, a system designed for organ perfusion. The entire project includes, among other things, GMP-standard research, preclinical studies on animal models, clinical trials up to the certification stage, and market readiness of the solution.
The net value of the submitted project is approximately PLN 31.3 million, with an estimated grant of around PLN 22.8 million and a self-contribution of approximately PLN 8.5 million.
More information about the competition results can be found on the PARP website: https://feng.parp.gov.pl/…/informacja-o-wynikach-oceny…